Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Life Science Awards.
Pfizer is in the firing line for UK complaints but is it one individual or lobby group time-wasting?
Author: Chris Wheal
Who is behind the string of anonymous complaints to the UK regulator? We try to find out and examine how the UK code is policed.
Janssen is to rebrand as Johnson & Johnson Innovative Medicine
Author: Chris Wheal
Janssen UK will immediately be known as Johnson & Johnson Innovative Medicine, with Ireland switching over in June.
Ireland’s pharma firms are EU’s third biggest exporter to the rest of the world
Author: Chris Wheal
The latest Eurostat figures show how important Ireland’s pharma sector is.
From Waterford to the world: stability storage firm Q1 Scientific on expansion into Belgium
Author: April Lara
Fresh from The Pharma Industry Awards, Q1 Scientific’s marketing manager, Karrena Legg, shares details on the storage specialist’s strategic move into Belgium.
Pharma and medical device makers have a ‘conflict of interest’ over health education funding
Author: Chris Wheal
Industry denies funding education and research in healthcare organisations presents a conflict of interest.
Irish MEPs urged to back pharma industry and reverse damaging EU legislation
Author: Chris Wheal
The Irish Pharmaceutical Healthcare Association (IPHA) is taking the fight against stifling over-regulation from the EU to the voters
Sparking debate: can the industry do more on energy and transport sustainability?
Author: Chris Wheal
More needs to be done faster to clean up the sector’s emissions. It’s easy to say but hard to achieve
Amie McNeice to lead marketing at Diaceutics on global expansion drive
Author: April Lara
Belfast and London R&D diagnostics firm aims for expansion in the US and Europe
UK companies get injection from first private Covid vaccine clinic
Author: Chris Wheal
The UK’s first non-NHS corporate Covid vaccine clinic gives 10 people the Pfizer jab.
IPHA and IDA Ireland slam EU for making US more attractive than Europe
Author: Chris Wheal
US regulation “has become more agile, more responsive”, while the EU “has moved in the opposite direction”, warns Michael Lohan.
